IMPACT-CABG Trial: Implantation of CD133<sup>+</sup> Stem Cells in Patients Undergoing Coronary Bypass Surgery—Presentation of the First Treated Patient

<table>Picture showing the intraoperative injection of the CD133<sup>+</sup> stem cells into the infarcted area and infarct border zone.</table>

Case Reports in Transplantation

fig1

Figure 1

Figure 1: IMPACT-CABG Trial: Implantation of CD133<sup>+</sup> Stem Cells in Patients Undergoing Coronary Bypass Surgery—Presentation of the First Treated Patient 

Figure 1 | IMPACT-CABG Trial: Implantation of CD133+ Stem Cells in Patients Undergoing Coronary Bypass Surgery—Presentation of the First Treated Patient 